Uncharacterized Protein, Uncharacterized
Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 15 |
NetGPI | no | yes: 0, no: 15 |
Related structures:
AlphaFold database: A4ICK7
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 103 | 105 | PF00675 | 0.520 |
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.445 |
CLV_NRD_NRD_1 | 121 | 123 | PF00675 | 0.455 |
CLV_NRD_NRD_1 | 30 | 32 | PF00675 | 0.598 |
CLV_PCSK_KEX2_1 | 103 | 105 | PF00082 | 0.529 |
CLV_PCSK_KEX2_1 | 12 | 14 | PF00082 | 0.623 |
CLV_PCSK_KEX2_1 | 121 | 123 | PF00082 | 0.538 |
CLV_PCSK_KEX2_1 | 157 | 159 | PF00082 | 0.541 |
CLV_PCSK_KEX2_1 | 24 | 26 | PF00082 | 0.548 |
CLV_PCSK_KEX2_1 | 30 | 32 | PF00082 | 0.589 |
CLV_PCSK_KEX2_1 | 45 | 47 | PF00082 | 0.661 |
CLV_PCSK_PC1ET2_1 | 12 | 14 | PF00082 | 0.611 |
CLV_PCSK_PC1ET2_1 | 157 | 159 | PF00082 | 0.538 |
CLV_PCSK_PC1ET2_1 | 24 | 26 | PF00082 | 0.384 |
CLV_PCSK_PC1ET2_1 | 45 | 47 | PF00082 | 0.658 |
CLV_PCSK_SKI1_1 | 103 | 107 | PF00082 | 0.498 |
CLV_PCSK_SKI1_1 | 12 | 16 | PF00082 | 0.556 |
CLV_PCSK_SKI1_1 | 24 | 28 | PF00082 | 0.590 |
DEG_Nend_Nbox_1 | 1 | 3 | PF02207 | 0.542 |
DOC_CYCLIN_yCln2_LP_2 | 35 | 41 | PF00134 | 0.572 |
DOC_MAPK_RevD_3 | 139 | 153 | PF00069 | 0.505 |
DOC_PP2B_LxvP_1 | 26 | 29 | PF13499 | 0.610 |
DOC_USP7_UBL2_3 | 153 | 157 | PF12436 | 0.442 |
DOC_WW_Pin1_4 | 12 | 17 | PF00397 | 0.591 |
DOC_WW_Pin1_4 | 45 | 50 | PF00397 | 0.585 |
DOC_WW_Pin1_4 | 91 | 96 | PF00397 | 0.621 |
LIG_14-3-3_CanoR_1 | 25 | 29 | PF00244 | 0.517 |
LIG_14-3-3_CanoR_1 | 54 | 60 | PF00244 | 0.512 |
LIG_AP2alpha_2 | 37 | 39 | PF02296 | 0.508 |
LIG_FHA_1 | 169 | 175 | PF00498 | 0.590 |
LIG_FHA_1 | 42 | 48 | PF00498 | 0.581 |
LIG_FHA_1 | 54 | 60 | PF00498 | 0.385 |
LIG_FHA_2 | 113 | 119 | PF00498 | 0.561 |
LIG_FHA_2 | 13 | 19 | PF00498 | 0.515 |
LIG_LIR_Apic_2 | 161 | 166 | PF02991 | 0.484 |
LIG_LIR_Gen_1 | 3 | 10 | PF02991 | 0.570 |
LIG_LIR_Nem_3 | 3 | 8 | PF02991 | 0.569 |
LIG_SH2_CRK | 126 | 130 | PF00017 | 0.516 |
LIG_SH2_CRK | 5 | 9 | PF00017 | 0.539 |
LIG_SH2_NCK_1 | 5 | 9 | PF00017 | 0.453 |
LIG_SH2_STAP1 | 160 | 164 | PF00017 | 0.518 |
LIG_SH2_STAP1 | 60 | 64 | PF00017 | 0.518 |
LIG_SH2_STAT5 | 163 | 166 | PF00017 | 0.493 |
LIG_SH2_STAT5 | 60 | 63 | PF00017 | 0.462 |
LIG_SH3_1 | 89 | 95 | PF00018 | 0.442 |
LIG_SH3_3 | 89 | 95 | PF00018 | 0.473 |
MOD_CK1_1 | 53 | 59 | PF00069 | 0.481 |
MOD_CK2_1 | 112 | 118 | PF00069 | 0.570 |
MOD_Cter_Amidation | 10 | 13 | PF01082 | 0.473 |
MOD_GlcNHglycan | 89 | 92 | PF01048 | 0.539 |
MOD_GSK3_1 | 164 | 171 | PF00069 | 0.525 |
MOD_GSK3_1 | 41 | 48 | PF00069 | 0.530 |
MOD_GSK3_1 | 83 | 90 | PF00069 | 0.536 |
MOD_LATS_1 | 22 | 28 | PF00433 | 0.405 |
MOD_N-GLC_1 | 130 | 135 | PF02516 | 0.698 |
MOD_NEK2_1 | 159 | 164 | PF00069 | 0.593 |
MOD_NEK2_1 | 186 | 191 | PF00069 | 0.711 |
MOD_NEK2_1 | 87 | 92 | PF00069 | 0.577 |
MOD_PIKK_1 | 58 | 64 | PF00454 | 0.482 |
MOD_PKA_1 | 112 | 118 | PF00069 | 0.604 |
MOD_PKA_1 | 152 | 158 | PF00069 | 0.406 |
MOD_PKA_1 | 24 | 30 | PF00069 | 0.575 |
MOD_PKA_2 | 127 | 133 | PF00069 | 0.639 |
MOD_PKA_2 | 24 | 30 | PF00069 | 0.501 |
MOD_PKA_2 | 53 | 59 | PF00069 | 0.527 |
MOD_PKA_2 | 83 | 89 | PF00069 | 0.507 |
MOD_Plk_1 | 98 | 104 | PF00069 | 0.499 |
MOD_Plk_4 | 159 | 165 | PF00069 | 0.542 |
MOD_Plk_4 | 83 | 89 | PF00069 | 0.672 |
MOD_ProDKin_1 | 12 | 18 | PF00069 | 0.584 |
MOD_ProDKin_1 | 45 | 51 | PF00069 | 0.578 |
MOD_ProDKin_1 | 91 | 97 | PF00069 | 0.616 |
MOD_SUMO_rev_2 | 108 | 115 | PF00179 | 0.631 |
TRG_ENDOCYTIC_2 | 146 | 149 | PF00928 | 0.396 |
TRG_ENDOCYTIC_2 | 5 | 8 | PF00928 | 0.574 |
TRG_ER_diArg_1 | 102 | 104 | PF00400 | 0.467 |
TRG_ER_diArg_1 | 120 | 122 | PF00400 | 0.398 |
TRG_ER_diArg_1 | 29 | 31 | PF00400 | 0.568 |
TRG_Pf-PMV_PEXEL_1 | 103 | 108 | PF00026 | 0.588 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P774 | Leptomonas seymouri | 27% | 100% |
A0A0N1HS21 | Leptomonas seymouri | 49% | 98% |
A0A0S4IZ88 | Bodo saltans | 23% | 99% |
A0A1X0P828 | Trypanosomatidae | 32% | 100% |
A0A3R7K1K7 | Trypanosoma rangeli | 34% | 100% |
A0A3S7XAJ8 | Leishmania donovani | 99% | 100% |
A0A422NMA5 | Trypanosoma rangeli | 28% | 100% |
A4HQ43 | Leishmania braziliensis | 27% | 100% |
D0A2V5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 33% | 100% |
D0A8S1 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 30% | 100% |
E9ADW1 | Leishmania major | 27% | 98% |
E9AIX6 | Leishmania braziliensis | 76% | 100% |
E9ASP8 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 93% | 100% |
E9ATW3 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 26% | 100% |
P17960 | Trypanosoma brucei brucei | 33% | 100% |